Skip to main content
Explore URMC

URMC Logo

menu

Suowen Xu, Ph.D.

Contact Information

Phone Numbers

Biography

Professional Background

Dr. Xu received his PhD degree in pharmacology from Sun Yat-Sen University (Guangzhou, China) in 2011. After graduation, he did his postdoctoral research at National Heart, Lung and Blood Institute/National Institutes of Health (NHLBI/NIH, Bethesda, MD) as a visiting fellow, studying the biochemistry and function of mono-ADP-ribosyltransferases (ARTs) and poly (ADPribose) polymerases (PARPs). In Feb 2014, he joined the Aab Cardiovascular Research Institute at the University of Rochester (Rochester, NY) as a postdoctoral research associate, studying epigenetic regulation of endothelial function by atheroprotective shear stress and associated vascular biology. He is a member of American Heart Association (AHA, since 2012) and American Association for the Advancement of Science (AAAS, since 2014). He acts as external reviewer for Health and Medical Research Fund (HMRF) of Hong Kong and General Research Fund of Research Grants Council (RGC) of Hong Kong.

Research

Dr. Xu is interested in finding new therapies to prevent/treat atherosclerosis, focusing specifically on: (1) identification of novel molecular mechanosensitive genes in atherosclerosis; (2) anti-aging strategies in physiological aging and progeria; (3) epigenetic processes that modulate endothelial function and atherosclerosis; (4) bioactive natural products-based drug discovery to treat atherosclerosis and related cardiometabolic diseases.

Credentials

Faculty Appointments

Education

2006
BS | China - Anhui University of Chinese Medicine
Pharmaceutical Sciences

2011
PhD | China-Sun Yat-sen University
Pharmacology

Awards

2016
American Heart Association Travel Award for Young Investigators
Sponsor: American Heart Association
Location: New Orleans, Louisiana

2010
New Investigator Award
Sponsor: Ministry of Education of China
Location: China